Title:
PHARMACEUTICAL PRODUCT FOR TREATMENT AND/OR PREVENTION OF CANCER
Document Type and Number:
WIPO Patent Application WO/2024/043258
Kind Code:
A1
Abstract:
This pharmaceutical product is useful for the treatment and/or prevention of cancer and contains the following components combined with each other in a blended or separated form: an antibody or a fragment thereof having immunological reactivity with a CAPRIN-1 protein; and a PDGFR inhibitor.
Inventors:
WASAI UKEI (JP)
OKANO FUMIYOSHI (JP)
SAITO TAKANORI (JP)
OKANO FUMIYOSHI (JP)
SAITO TAKANORI (JP)
Application Number:
PCT/JP2023/030241
Publication Date:
February 29, 2024
Filing Date:
August 23, 2023
Export Citation:
Assignee:
TORAY INDUSTRIES (JP)
International Classes:
A61K39/395; A61K31/44; A61K45/00; A61P35/00; A61P35/02; A61P43/00; C07K16/28
Domestic Patent References:
| WO2021182573A1 | 2021-09-16 |
Other References:
山田一彦, 多標的分子標的治療薬, 日本臨牀, 2009, vol. 67, 増刊号1(がん薬物療法学), pp. 301-305, ISSN 0047-1852, (Japanese Journal of Clinical Medicine.), non-official translation (YAMADA, Kazuhiko. Multi-target molecular targeted therapy, special issue 1 (Cancer pharmacotherapy).)
NISHIOKA, YASUHIKO, SONE, SABURO: "Molecularly targeted therapeutic drugs that target multiple molecules", JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, BIOMEDICAL DRUGS PUBLICATION, JP, vol. 224, no. 13, 1 January 2008 (2008-01-01), JP , pages 1114 - 1117, XP009552943, ISSN: 0039-2359
小寺康夫, 多標的チロシンキナーゼ阻害剤の種類と特徴, Mebio. 2009, vol. 26, no. 5, pp. 74-83, ISSN 0910-0474, non-official translation (KODERA, Yasuo. Types and characteristics of multi-targeted tyrosine kinase inhibitors.)
NISHIOKA, YASUHIKO, SONE, SABURO: "Molecularly targeted therapeutic drugs that target multiple molecules", JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, BIOMEDICAL DRUGS PUBLICATION, JP, vol. 224, no. 13, 1 January 2008 (2008-01-01), JP , pages 1114 - 1117, XP009552943, ISSN: 0039-2359
小寺康夫, 多標的チロシンキナーゼ阻害剤の種類と特徴, Mebio. 2009, vol. 26, no. 5, pp. 74-83, ISSN 0910-0474, non-official translation (KODERA, Yasuo. Types and characteristics of multi-targeted tyrosine kinase inhibitors.)
Download PDF:
Previous Patent: MEDICAMENT FOR TREATMENT AND/OR PREVENTION OF CANCER
Next Patent: DUPLEX STAINLESS STEEL MATERIAL
Next Patent: DUPLEX STAINLESS STEEL MATERIAL